Pharmaco-metabonomic phenotyping and personalized drug treatment. - Wikidata - awgldk - TriplyDB

Pharmaco-metabonomic phenotyping and personalized drug treatment.

Pharmaco-metabonomic phenotyping and personalized drug treatment.

http://www.wikidata.org/entity/Q34515169

about

Metabolomics: moving towards personalized medicine Applications of metabolomics in cancer research Stable isotope-resolved metabolomics and applications for drug development Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates The human intestinal microbiome: a new frontier of human biology Global systems biology, personalized medicine and molecular epidemiology Animal-Free Chemical Safety Assessment Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room Blood transcriptomics and metabolomics for personalized medicine The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?Metabolomic fingerprinting: challenges and opportunities Big data: the next frontier for innovation in therapeutics and healthcare 3D Printed Anatomical Nerve Regeneration Pathways From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice Systematic NMR analysis of stable isotope labeled metabolite mixtures in plant and animal systems: coarse grained views of metabolic pathways Evaluation and characterization of bacterial metabolic dynamics with a novel profiling technique, real-time metabolotyping Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses An effective assessment of simvastatin-induced toxicity with NMR-based metabonomics approach Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells Prediction of the pharmacokinetic parameters of triptolide in rats based on endogenous molecules in pre-dose baseline serum Pharmacometabolomic approach to predict QT prolongation in guinea pigs Comparison of Bile Acids and Acetaminophen Protein Adducts in Children and Adolescents with Acetaminophen Toxicity Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats Integrative network modeling approaches to personalized cancer medicine Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures COordination of Standards in MetabOlomicS (COSMOS): facilitating integrated metabolomics data access Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats The metabolic signature related to high plant growth rate in Arabidopsis thaliana Metabolomics enables precision medicine: "A White Paper, Community Perspective"Large-scale prediction of drug-target relationships Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions.Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure Statistical HOmogeneous Cluster SpectroscopY (SHOCSY): an optimized statistical approach for clustering of ¹H NMR spectral data to reduce interference and enhance robust biomarkers selection

P2860

Q21198748-772B074B-56CA-4D32-9712-0FDEE69170D2 Q24600728-F778D7AA-DDBA-45BD-A2F3-0BA5281298AF Q24629149-C1ABBF19-0C2A-4CC4-A251-17A10C23F1EC Q24647414-10CABE1E-5765-4F74-BB05-9DE12D4B4266 Q24649671-128E5BE2-F333-4C44-ACC8-D7A1309A59F8 Q24671979-4933B225-5B5E-407C-8617-91230948036B Q26738977-253998FA-73A9-4D3B-A2E5-E9E069C15E07 Q26741270-151BD2F3-98FF-47EB-AE04-4FA5FFFB19F4 Q26742050-15326BD5-B5EA-4C57-9DF2-F403BA62D874 Q26748481-DCB94A64-2492-4492-A1F4-E68C9A2A11E7 Q26768636-0554BC22-DEF3-4300-85F2-19909B8F4CB6 Q26772073-D99C47B3-A43B-45BF-BFD0-7C6478139062 Q26772999-784A6B38-00D9-4ED9-9B44-A4BE79D91DB4 Q26829105-7F6667A1-ABCB-4202-BFFB-7955912A9026 Q27027248-C3A80262-EDC5-406F-A0DD-20C7065C21E7 Q27342772-6198A7C9-4777-4EE8-A249-1E497465ED8D Q28067029-3F36C7D1-463E-4C01-AFB0-974B36CC153D Q28083342-5E1EA801-13E1-41A6-9437-64FC6BCC4B33 Q28472224-EE3FE91D-A88C-4458-9D49-129DB03E029B Q28472438-2CA97151-5E1C-4AF6-B586-D58731A1D33E Q28474093-2DA7049F-D3FF-4CD2-8461-3EDF5376DFAD Q28475065-1019962A-CAB2-4400-B026-A570B4CDD2CB Q28475717-0D8695B4-D9AA-48E0-B826-5D4769F63C15 Q28477228-5F702517-3E89-4E00-BA03-38AD43C64232 Q28477468-434D4778-9C61-488A-99AA-662416983BA2 Q28477581-CE4CD724-A1CD-4994-8086-EB223B20A1C1 Q28482330-D939AD12-E15E-4BC0-B9D7-EB3C672439B4 Q28485993-C1D56CA6-3280-4A58-B31C-D9983B56A439 Q28546783-0C6F0D76-7821-4DF6-A16B-8CFDBE971313 Q28550555-E6E1A016-3F6E-4CEE-BA5B-4840435AE24C Q28602016-57B4AB9F-3B4A-4B26-86EA-2FFDA18A3C1F Q28607220-DAA1A04E-C766-4DED-B764-A4B58192A732 Q28611417-ED1B4F7A-34DD-410F-BF1D-209680F231E8 Q28656449-8958D867-3456-4C4C-9C92-334864F0ED2D Q28763313-6AE33A5F-35FE-4FF6-B855-059EEBD1AF7E Q28831476-6032FF09-9DD7-441A-8978-68748A9E60DE Q30002408-AD837B3D-3CBC-4B94-8C2C-345221518777 Q30274820-BD3F0070-3931-408E-9C6D-503648D48A34 Q30538147-A091CB27-87D8-4C63-A8F1-BB08B6FA83A8 Q30810580-BB00913D-BBCE-4597-8960-71D772FB6DAC

P2860

Pharmaco-metabonomic phenotyping and personalized drug treatment.

http://www.wikidata.org/entity/Q34515169

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@ast

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@en

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@nl

type

label

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@ast

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@en

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@nl

prefLabel

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@ast

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@en

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@nl

P1433

Q34515169-5CFD29BA-6BA8-4330-993B-CEAEFDCF9223

P1476

Q34515169-235C3620-AD6C-4FB7-A8CA-47A11E7F6BAF

P2093

Q34515169-0318CF9E-C9BE-43E3-BBE1-727F1E6F508D

Q34515169-1B00F39F-D78A-4A45-9E5B-5A268367F7AD

Q34515169-503E9FD4-D880-4471-8A89-BE161BECEA7A

Q34515169-731BC80A-8E0D-40B3-B574-3D0FE0B718FE

Q34515169-7CC80A50-7E8B-4028-971B-59C7ED1E6686

Q34515169-85429C0F-8B1F-4CEB-B964-C3234DF3728B

Q34515169-A33D7EA0-1B99-4A27-9A30-B3A3E3B1E49C

Q34515169-AC86DD0C-8950-43A3-B3C2-09252270230C

Q34515169-E9C1DAC4-B260-4AA0-B220-7038F660B0EA

Q34515169-E9CC52AF-4772-4E2B-8D1B-162D754BCA14

P2860

Q34515169-0CFA2525-6025-4680-8B51-052C4FBC1D5F

Q34515169-10C5153F-CAE1-47ED-ABCB-34AA28B44ADE

Q34515169-11F37766-847A-4F8D-B30C-ECFD2E9D6BC0

Q34515169-1F33A34F-B0C7-4063-9942-C86089A4A4FF

Q34515169-3799FE0C-FAB7-4CE7-87C3-984FB3B9DCAB

Q34515169-3A2F6C6F-A903-4B78-BD1B-EC5EFCEC1328

Q34515169-49BC3191-6792-48A6-BFF9-3F7AA0A4B1E8

Q34515169-708EB665-D0D6-4442-836E-C425F9423058

Q34515169-848D0300-E8C0-42A9-865B-4B5236C7AC42

Q34515169-A80C349F-1937-4B95-996B-A78A6332863A

P2888

Q34515169-5FC8E3BC-0875-4350-82B0-06BF606819A1

P304

Q34515169-7191521D-57CD-4D71-85F8-77C91E1E50CA

P31

Q34515169-B09396CD-C8A3-4E26-B757-34E8C6493AA0

P356

Q34515169-212C5E49-4C3D-4574-86F8-DC97DC151AD7

P407

Q34515169-166ECB4E-35C4-4669-9C1D-533A7DA0D13E

P433

Q34515169-D70091AF-6F6A-41AE-8A9C-646871093A24

P478

Q34515169-66A410F9-B354-408D-947A-61C6F2B6690F

P50

Q34515169-1AC125F5-305D-4F0B-813C-E3A5E64C15FC

Q34515169-80A361CE-12BC-4B5C-B4A0-6616C5D318D7

P577

Q34515169-6E3BEC4E-7897-4795-9770-28D5AEFB699C

P5875

Q34515169-DC30D878-79A6-40E7-ADB6-9F13D22195EF

P6179

Q34515169-DCAE8AC6-11B1-4A13-8030-008B6D8363F2

P698

Q34515169-A98F0BB9-2B36-418C-912C-07E5136B8FC3

P356

P1433

P1476

Pharmaco-metabonomic phenotyping and personalized drug treatment.

@en

P2093

Claude Charuel

http://www.w3.org/2001/XMLSchema#string

David Baker

http://www.w3.org/2001/XMLSchema#string

Gilles Hanton

http://www.w3.org/2001/XMLSchema#string

Henrik Antti

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Provost

http://www.w3.org/2001/XMLSchema#string

Jeremy R Everett

http://www.w3.org/2001/XMLSchema#string

John C Lindon

http://www.w3.org/2001/XMLSchema#string

Olivier Cloarec

http://www.w3.org/2001/XMLSchema#string

Rosalind J Walley

http://www.w3.org/2001/XMLSchema#string

T Andrew Clayton

http://www.w3.org/2001/XMLSchema#string

P2860

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets.

Metabonomics: a platform for studying drug toxicity and gene function.

Genetic variability in susceptibility and response to toxicants.

A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin?

Metabonomic applications in toxicity screening and disease diagnosis.

Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.

Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements.

The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.

The in vivo and in vitro protective properties of taurine.

P2888

P304

1073-1077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE04648

http://www.w3.org/2001/XMLSchema#string

P407

P433

7087

http://www.w3.org/2001/XMLSchema#string

P478

440

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy K. Nicholson

Jean-Loïc Le Net

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7155669

http://www.w3.org/2001/XMLSchema#string

P6179

1026508206

http://www.w3.org/2001/XMLSchema#string

P698

16625200

http://www.w3.org/2001/XMLSchema#string